2023-11-16T23:29:40-06:00 2022-12-31 750786316 WEAVER AND TIDWELL LLP 2300 N FIELD ST STE 1000 DALLAS TX 75201 990 2022-01-01 510151514 RETINA FOUNDATION OF THE SOUTHWEST RETI 2143633911 PO BOX 824189 DALLAS TX 753824189 KARL CSAKY CHIEF EXECUTIVE & MEDICAL OFFICER 2143633911 2023-11-15 1 KARL CSAKY 999009999 1 SARA BURKHART P01435955 9724901970 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z KARL CSAKY PO BOX 824189 DALLAS TX 753824189 5732563 0 X WWW.RETINAFOUNDATION.ORG X 1975 TX THE FOUNDATION WAS ORGANIZED TO PROMOTE THE RESEARCH, DIAGNOSIS, TREATMENT AND EDUCATION OF THE LEADING CAUSES OF BLINDNESS AND IMPAIRED VISION. THE FOUNDATION ALSO STRIVES TO INCREASE THE UNDERSTANDING OF THE NORMAL DEVELOPMENT AND FUNCTION OF THE VISUAL SYSTEM IN ORDER TO PREVENT, DIAGNOSE AND TREAT SIGHT-THREATENING CONDITIONS, AND TO ENHANCE THE REHABILITATION, TRAINING AND QUALITY OF LIFE OF INDIVIDUALS WHO ARE PARTIALLY SIGHTED OR BLIND. 21 21 49 56 0 0 5274882 5583143 0 0 1974 70614 -40864 -68993 5235992 5584764 10509073 0 0 0 3431151 3724894 0 0 590846 1388090 1757093 15328314 5481987 -10092322 102777 12529577 13298686 373955 1040287 12155622 12258399 THE MISSION OF THE RETINA FOUNDATION OF THE SOUTHWEST IS TO PREVENT VISION LOSS AND RESTORE SIGHT THROUGH INNOVATIVE RESEARCH AND TREATMENT. 0 0 4258209 STUDIES TO DETERMINE THE NECESSARY AND SUFFICIENT CONDITIONS FOR THE DEVELOPMENT OF NORMAL BINOCULAR VISION IN INFANTS FROM BIRTH TO AGE FIVE. CLINICAL TREATMENT TRIALS FOR RETINITIS PIGMENTOSA, CHOROIDEREMIA, RETINOSCHESIS AND AGE-RELATED MACULAR DEGENERATION. RESEARCH INTO GENES CAUSING CERTAIN INHERITED EYE DISEASES MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITY. RESEARCH TO DEVELOP A DEVICE FOR OCULAR DELIVERY OF DRUGS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION. VARIOUS OTHER RESEARCH PROJECTS. 4258209 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 58 0 1 49 1 0 0 0 0 0 0 0 0 0 0 0 0 X 21 21 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X KARL CSAKY 2143633911 PO BOX 824189 DALLAS TX 753824189 RAJIV ANAND MD DIRECTOR 1.00 X 0 0 0 DIANE BODDY DIRECTOR 1.00 X 0 0 0 MEHMET CANDAS PHD DIRECTOR 1.00 X 0 0 0 ALEX M CENA DIRECTOR 1.00 1.00 X 0 0 0 LORI DAO MD DIRECTOR 1.00 X 0 0 0 LAURIE DOTTER CPA DIRECTOR 1.00 X 0 0 0 REHAM EL-SHERAZI CPA DIRECTOR 1.00 X 0 0 0 WILLIAM L HUTTON MD DIRECTOR 1.00 1.00 X 0 0 0 MARC H KLEIN DIRECTOR 1.00 X 0 0 0 RICHARD A MASSMAN DIRECTOR 1.00 1.00 X 0 0 0 JAMES H MERRITT MD DIRECTOR 1.00 X 0 0 0 MICKEY MUNIR DIRECTOR 1.00 X 0 0 0 EVELYN J PULLIAM DIRECTOR 1.00 X 0 0 0 THERESE ROURK DIRECTOR 1.00 X 0 0 0 RICHARD SCHAAR PHD DIRECTOR 1.00 X 0 0 0 RAND SPENCER MD DIRECTOR 1.00 X 0 0 0 TIA S TOMLIN DIRECTOR 1.00 X 0 0 0 ROBERT WANG MD DIRECTOR 1.00 X 0 0 0 STEVEN EISNAUGLE TREASURER 1.00 X X 0 0 0 LOUIS GRABOWSKY CHAIR 1.00 1.00 X X 0 0 0 NANCY ROGERS SECRETARY 1.00 X X 0 0 0 KARL CSAKY CHIEF EXECUTIVE AND MEDICAL OFFICER 29.00 1.00 X 329453 0 14144 NATALIE GILBERT FINANCE DIRECTOR 39.00 1.00 X 129564 0 14879 DAVID BIRCH SCIENTIFIC DIRECTOR 40.00 X 290854 0 22741 EILEEN BIRCH PEDIATRIC LAB DIRECTOR 40.00 X 288798 0 22829 KRISTA KELLY ASSISTANT SCIENTIFIC DIRECTOR 40.00 X 115645 0 13980 AMY JOHNSON CHIEF DEVELOPMENT OFFICER 40.00 X 172492 0 16881 LUCINDA BAILLIE BUSINESS OPERATIONS MANAGER 40.00 X 107414 0 13556 KIRSTEN LOCKE CLINICAL TRIALS MANAGER 40.00 X 100636 0 13365 1534856 0 132375 8 0 1 0 0 707236 399985 943241 3532681 5583143 70614 70614 46320 707236 147799 -101479 -101479 OTHER INCOME 900099 32486 32486 32486 5584764 0 0 1621 1113260 903711 170485 39064 2131925 1659412 207491 265022 84135 66896 4444 12795 189098 153414 15763 19921 206476 157292 27500 21684 37379 19115 13003 5261 54344 54344 74165 26981 4808 42376 101658 101658 270896 163593 58807 48496 191007 165565 16852 8590 67927 61640 833 5454 8506 7809 440 257 231239 202303 24152 4784 61510 43209 16030 2271 DIRECT PROGRAM EXPENSES 288793 288793 SUBCONTRACTOR AGREEMENT 251657 251657 OTHER EXPENSES 75246 44053 17980 13213 LECTURE SERIES 42766 42766 5481987 4258209 632932 590846 92146 30903 7300878 7461268 1355898 1578492 72168 59063 6524116 2355156 3708487 4168960 12529577 13298686 318266 619971 55689 46507 0 373809 373955 1040287 X 7624528 7577911 4531094 4680488 12155622 12258399 12529577 13298686 102777 0 X X 0 1 X 1 1 1 X 4849427 5217266 5759915 5275882 5596830 26699320 4849427 5217266 5759915 5275882 5596830 26699320 5930530 20768790 285040 394698 286857 1974 70614 1039183 59825 65771 72754 33560 32483 264393 28002896 0.74170 0.72670 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10397738 111335 10509073 10097769 682666 382697 10397738 8845554 1622105 369890 10097769 9816316 -611685 359077 8845554 250000 250000 3404273 1495842 1908431 2869843 859314 2010529 4168960 X 5699927 0 5699927 -115163 -115163 5584764 5597150 0 5597150 -115163 -115163 5481987 PART V, LINE 4: RESEARCH AND GENETIC TESTING AND COUNSELING TO IMPROVE VISION FOR PATIENTS WITH AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, RETINAL DISORDERS AND CHILDREN WITH CATARACTS, AMBLYOPIA, NASTAGMUS AND STRABISMUS PART X, LINE 2: THE FOUNDATION HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS A NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX ON ITS INCOME, UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE FOUNDATION FOLLOWS THE PROVISIONS OF ASC 740-10, INCOME TAXES, RELATED TO UNRECOGNIZED TAX POSITIONS. THE FOUNDATION RECOGNIZES THE TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY THE TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH POSITIONS ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE FOUNDATION DOES NOT BELIEVE THERE ARE ANY MATERIAL UNCERTAIN TAX POSITIONS AND ACCORDINGLY, IT WILL NOT RECOGNIZE ANY LIABILITY FOR UNRECOGNIZED TAX BENEFITS. FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021, THERE WERE NO INTEREST OR PENALTIES RECORDED OR INCLUDED IN THE FINANCIAL STATEMENTS. THE FOUNDATION IS RELYING ON ITS TAX-EXEMPT STATUS AND ITS ADHERENCE TO ALL APPLICABLE LAWS AND REGULATIONS TO PRESERVE THAT STATUS. HOWEVER, THE CONCLUSIONS REGARDING ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES WILL BE SUBJECT TO REVIEW AND MAY BE ADJUSTED AT A LATER DATE BASED ON FACTORS INCLUDING, BUT NOT LIMITED TO, ONGOING ANALYSIS OF TAX LAWS, REGULATIONS, AND INTERPRETATIONS THEREOF. THE FOUNDATION'S INFORMATIONAL RETURNS ARE GENERALLY SUBJECT TO EXAMINATION FOR THREE YEARS AFTER THE LATER OF THE DUE DATE OR DATE OF FILING. AS A RESULT, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY TAX AUTHORITIES FOR YEARS PRIOR TO 2019. PART XI, LINE 4B - OTHER ADJUSTMENTS: DIRECT EXPENSES FOR FUNDRAISING EVENT -101,479. ADDITIONAL SPECIAL EVENT EXPENSES -13,684. PART XII, LINE 4B - OTHER ADJUSTMENTS: DIRECT EXPENSES FOR FUNDRAISING EVENT -101,479. ADDITIONAL SPECIAL EVENT EXPENSES -13,684. VISIONARY LUNCHEON 753556 707236 46320 32636 46320 68843 753556 707236 46320 32636 46320 68843 147799 -101479 X X 0 0 0 0 0 0 0 0 0 KARL CSAKY CHIEF EXECUTIVE AND MEDICAL OFFICER 329453 0 0 0 0 0 13908 0 236 0 343597 0 0 0 DAVID BIRCH SCIENTIFIC DIRECTOR 290854 0 0 0 0 0 14355 0 8386 0 313595 0 0 0 EILEEN BIRCH PEDIATRIC LAB DIRECTOR 288798 0 0 0 0 0 14440 0 8389 0 311627 0 0 0 AMY JOHNSON CHIEF DEVELOPMENT OFFICER 172492 0 0 0 0 0 8486 0 8395 0 189373 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 DAVID BIRCH AND EILEEN BIRCH HAVE A FAMILY RELATIONSHIP. THEY ARE BOTH KEY EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY MEMBERS OF THE FINANCE AND AUDIT COMMITTEE PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTEREST ARE ADDRESSED IN THE BOARD MEETINGS. MEMBERS MUST SIGN THE CONFLICT OF INTEREST STATEMENT ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE MEETS EVERY YEAR AND EVALUATES AND APPROVES THE COMPENSATION OF THE KEY EMPLOYEES. A PART OF THIS PROCESS INCLUDES COMPARING THEM TO OTHER INSTITUTIONS LIKE THE RETINA FOUNDATION OF THE SOUTHWEST. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S DOCUMENTS ARE AVAILABLE AT WWW.GUIDESTAR.ORG AND UPON REQUEST. FORM 990, PART XII, LINE 2C THERE HAS BEEN NO CHANGE IN THE OVERSIGHT OR SELECTION PROCESS OF THE INDEPENDENT ACCOUNTANT IN THE PAST YEAR. RFSW ENDOWMENT INC PO BOX 824189 DALLAS TX 753824189 851208107 INVESTMENTS TX 501(C)(3) LINE 7 RETINA FOUNDATION OF THE SOUTHWEST 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 RFSW ENDOWMENT INC C 399985 CASH